OCTOBER 27, 2008 -- The Molecular Imaging and Contrast Agent Database (MICAD) has added a number of new probes, including two for optical molecular imaging: QD-Apt(Dox), which targets a prostate-specific membrane antigen, and IR-2, which targets lysosomes.
These and 544 other agents for various modalities -- including optical -- are available in the MICAD database.
MICAD is a key component of the NIH Roadmap; it is developed by the National Center for Biotechnology Information (NCBI), at the National Institutes of Health (NIH). The mission of the MICAD program is to foster research and development in molecular imaging by providing free accessible online scientific information on in vivo molecular imaging and contrast agents to the community working in the field.
The Molecular Imaging and Contrast Agent Database (MICAD)